FilingReader Intelligence
United Laboratories forecasts strong profit growth from license fees
August 18, 2025 at 10:31 AM UTC•By FilingReader AI
United Laboratories International Holdings expects net profit of approximately 1.85 billion yuan for the six months ended June 30, 2025, up from 1.49 billion yuan in the prior year.
The increase is mainly due to about 1.1 billion yuan in license fee income from Novo Nordisk, despite segment profit declines of 430 million yuan in intermediate products and 270 million yuan in bulk medicine.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
HKEX:3933•Hong Kong Exchange
News Alerts
Get instant email alerts when The United Laboratories International Holdings publishes news
Free account required • Unsubscribe anytime